Valeant Pharma (VRX) Posts Weaker Q4 EPS; Guides FY11 EPS
Tweet Send to a FriendGet Alerts VRX Hot Sheet
Price: $78.17 +3.19%
EPS Growth %: +31.3%
Financial Fact:
Shares used in per share computation - Basic: 77.14M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: +31.3%
Financial Fact:
Shares used in per share computation - Basic: 77.14M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade VRX Now!
Valeant Pharmaceuticals International (NYSE: VRX) reported Q4 EPS of $0.51, versus $0.84 last year. Revenue for the quarter came in at $514.6 million versus the consensus estimate of $297.08 million.
Sees FY2011 EPS of $2.45-$2.70.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees FY2011 EPS of $2.45-$2.70.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Donaldson Co., Inc. (DCI) Misses Q3 EPS by 3c; Guides FY13 Below Views
- J.C. Penney Co., Inc. (JCP) Posts Q1 Loss of $1.31/Share; Comps Down 16.6%
Create E-mail Alert Related Categories
Earnings, Guidance
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
